Commentary: A targets framework: Dismantling the invisibility trap for children with drug-resistant tuberculosis

Journal of Public Health Policy

Volumn 35, Issue 4, 2014, Pages 425-454

  Becerra, Mercedes C ^a   Swaminathan, Soumya ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

contact investigation; MDR TB; monitoring; pediatric; prevention

Indexed keywords

TUBERCULOSTATIC AGENT;

ADOLESCENT; AGE; CHILD; HEALTH; HUMAN; PRESCHOOL CHILD; SENTINEL SURVEILLANCE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ADOLESCENT; AGE FACTORS; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; GLOBAL HEALTH; HUMANS; SENTINEL SURVEILLANCE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84949116252     PISSN: 01975897     EISSN: 1745655X     Source Type: Journal    
DOI: 10.1057/jphp.2014.35     Document Type: Review

References (120)

1. World Health Organization. (2013) Global Tuberculosis Report 2013. Geneva, Switzerland: World Health Organization.
2. Nelson L.J. and Wells C.D. (2004) Global epidemiology of childhood tuberculosis. International Journal of Tuberculosis and Lung Disease 8(5): 636-647.
3. Jenkins H.E. et al (2014 Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates The Lancet 383 9928 1572-1579.
4. Dodd P.J., Gardiner E., Coghlan R. and Seddon J.A. (2014) Burden of childhood tuberculosis in 22 high-burden countries: A mathematical modelling study. The Lancet Global Health 2(8): 453-459.
5. Marais B.J. and Schaaf H.S. (2010) Childhood tuberculosis: An emerging and previously neglected problem. Infectious Disease Clinics of North America 24(3): 727-749.
6. Donald P.R. (2002) Childhood tuberculosis: Out of control? Current Opinion in Pulmonary Medicine 8(3): 178-182.
7. Keshavjee S. and Seung K.J. (2009) Stemming the tide of multidrug-resistant tuberculosis: Major barriers to addressing the growing epidemic. In: National Research Council (ed.) Address ing the Threat of Drug-Resistant Tuberculosis: A Realistic Assessment of the Challenge: Workshop Summary. Washington DC: The National Academies Press.
8. National Research Council. (2011) The Emerging Threat of Drug-Resistant Tu berculosis in Southern Africa: Global and Local Challenges and Solutions: Summary of a Joint Workshop by the Institute of Medicine and the Academy of Science of South Africa. Washington DC: The National Academies Press.
9. National Research Council. (2011) The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop by the Institute of Medicine and the Russian Academy of Medical Sciences. Washin gton DC: The National Academies Press.
10. National Research Council. (2012) Facing the Reality of Drug-Resistant Tuberculosis: Challenges and Potential Solutions in India: Summary of a Joint Workshop by the Institute of Medicin e, the Indian National Science Academy, and the Indian Council of Medical Research. Washington DC: The National Academies Press.
11. National Research Council. (2013) Developing and Strengthening the Global Supply Chain fo r Second-Line Drugs for Multidrug-Resistant Tuberculosis: Workshop Summary. Washington DC: The National Academies Press.
12. National Research Council. (2014) The Global Crisis of Drug-Resistant Tuberculosis and Leadership of Ch ina and the BRICS: Challenges and Opportunities: Summary of a Joint Workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences. Washington DC: The National Academies Press.
13. Zhao Y. e t al (2012) National survey of drug-resistant tuberculosis in China. New England Journal of Medicine 366(23): 2161-2170.
14. Yuen C.M., Tolman A.W., Cohen T., Parr J.B., Keshavjee S. and Becerra M.C. (2013) Isoniazid-resistant tuberculosis in children: A systematic review. The Pediatric Infectious Disease Journal 32(35): e217-e226.
15. Zignol M., Sismanidis C., Falzon D., Glaziou P., Dara M. and Floyd K. (2012) Multidrugresistant tuberculosis in children: Evidence from global surveillance. European Respiratory Journal 42(3): 701-707.
16. Orenstein E.W. et al (2009) Treatment outcomes among patients with multidrug-resistant tuberculosis: Systematic review and meta-analysis. The Lancet Infectious Diseases 9(3): 153-161.
17. Ettehad D., Schaaf H.S., Seddon J.A., Cooke G.S. and Ford N. (2012) Treatment outcomes for children with multidrug-resistant tuberculosis: A systematic review and meta-analysis. The Lancet Infectious Diseases 12(6): 449-456.
18. Mitnick C.D. et al (2013) Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality. PLOS ONE 8(3): e58664.
19. Seung K.J. et al (2004) The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis. Clinical Infectious Diseases 39(9): 1321-1328.
20. Friedman C.R. et al (1995) Transmission of multidrug-resistant tuberculosis in a large urban setting. American Journal of Respiratory and Critical Care Medicine 152(1): 355-359.
21. Centers for Disease Control and Prevention. (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. Morbidity and Mortality Weekly Report 49(RR-6): 1-51.
22. Partners In Health. (2003) The PIH Guide to the Medical Management of Multidrug-Resistant Tuberculosis. Boston, MA: Partners In Health.
23. Tuberculosis Coalition for Technical Assistance. (2006) International Standards for Tuberculosis Care (ISTC). The Hague: Tuberculosis Coalition for Technical Assistance.
24. World Health Organization. (2006) Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. Geneva, Switzerland: World Health Organization.
25. Keshavjee S. and Farmer P.E. (2012) Tuberculosis, drug resistance, and the history of modern medicine. New England Journal of Medicine 367(10): 931-936.
26. Keshavjee S. and Farmer P.E. (2010) Picking up the pace-Scale-up of MDR tuberculosis treatment programs. New England Journal of Medicine 363(19): 1781-1784.
27. Mitnick C.D., Keravec J. and Cohen T. (2013) Planning for the invisible: Projecting resources needed to identify and treat all patients with MDR-TB. International Jour nal of Tuberculosis and Lung Disease 17(4): 427-428.
28. Childhood TB Subgroup of the Stop TB Partnership. (2013) Roadmap for childhood tuberculosis: Towards zero deaths. Geneva, Switzerland: World Health Organization. http://apps.who.int/iris/bitstream/10665/89506/1/9789241506137-eng.pdf, accessed 15 April 2013.
29. Beyers N. and Gie R. (2013) Childhood tuberculosis: No longer an orphan disease? Public Health Action 3(3): 190.
30. World Health Organization. (2006) Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children. Geneva, Switzerland: World Health Organization.
31. World Health Organization. (2014) Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children-Second Edition. Geneva, Switzerland: World Health Organization.
32. Brent A.J., A nderson S.T. and Kampmann B. (2008) Childhood tuberculosis: Out of sight, out of mind? Transactions of the Royal Society of Tropical Medicine and Hygiene 102(3): 217-218.
33. du Cros P., Nyang'w a B.T., Gale M., Venis S. and Ford N. (2011) Counting children: Comparing reporting for paediatric HIV and tuberculosis. Bulletin of the World Health Organization 89(12): 855.
34. Mé decins Sans Frontières. (2011) Out of the Dark: Meeting the Needs of Children with TB. Geneva, Switzerland: Médecins Sans Frontiè res, http://www.msfaccess.org/content/out-darkmeeting-needs-of-children-with-TB, accessed: 28 July 2012.
35. Action Pro ject. (2011) Children and tuberculosis: Exposing a hidden epidemic, http://c1280352.r52.cf0.rackcdn.com/childrens-tb-0811v2.pdf, accessed 15 April 2013.
36. Stop TB Partnership. (2012) No More Crying, No More Dying. Towards Zero TB Deaths in Children. Geneva, Switzerland: World Health Organization, http://www.stoptb.org/assets/documents/news/ChildhoodTB-report-singles.pdf, accessed: 15 April 2013.
37. Feja K. and Saiman L. (2005) Tuberculosis in children. Clinics in ChestMedicine 26(2): 295-312.
38. Newton S.M., Brent A.J., Anderson S., Whittaker E. and Kampmann B. (2008) Paediatric tuberculosis. The Lancet Infectious Diseases 8(8): 498-510.
39. Perez-Velez C.M. and Marais B.J. (2012) Tuberculosis in children. New England Journal of Medicine 367(4): 348-361.
40. Jones C., Whittaker E., Bamford A. and Kampmann B. (2011) Immunology and pathogenesis of childhood TB. Paediatric Respiratory Reviews 12(1): 3-8.
41. Conne ll T.G., Zar H.J. and Nicol M.P. (2011) Advances in the diagnosis of pulmonary tuberculosis in HIV-infected and HIV-uninfected children. The Journal of Infectious Diseases 204(Suppl. 4): S1151-1158.
42. Star ke J.R. (2001) Childhood tuberculosis: Treatment strategies and recent advances. Paediatric Respiratory Reviews 2(2): 103-112.
43. Graham S. (2010) Desk-guide for diagnosis and management of TB i n children. Paris, France: The International Union Against Tuberculosis and Lung Disease, http://www.theunion.org/what-we-do/publications/technical/english/pub-tbdeskguide-eng.pdf, accessed 15 April 2013.
44. Seddon J.A. et al (2012) Caring for children with drug-resistant tuberculosis: Practice-based recommendations. American Journal of Respiratory and Critical Care Medicine 186(10): 953-964.
45. Cuevas L.E., Petru cci R. and Swaminathan S. (2012) Tuberculosis diagnostics for children in high-burden countries: What is available and what is needed. Paediatrics and International Child Health 32(Suppl. 2): S30-37.
46. Marais B.J. Gie R.P. Schaaf H.S. Beyers N. Donald P.R. Starke J.R. 2006 Childhood pulmonary tuberculosis: Old wisdom and new challenges American Journal of Respiratory and Critical Care Medicine 173 10 1078-1090.
47. Shingadia D. and Novelli V. (2003) Diagnosis and treatment of tuberculosis in children. The Lancet Infectious Diseases 3(10): 624-632.
48. Reubenson G. (2011) Pediatric drug-resistant tuberculosis: A global perspective. Paediatric Drugs 13(6): 349-355.
49. World Health Organization Global Tuberculosis Programme. (1994) Framework for Effective Tuberculosis Control. Geneva, Switzerland: World Health Organization.
50. Murray C.J., Styblo K. and Rouillon A. (1990) Tuberculosis in developing countries: Burden, intervention and cost. Bulletin of the International Union Against Tuberculosis and Lung Disease 65(1): 6-24.
51. Khan E.A. and Starke J.R. (1995) Diagnosis of tuberculosis in children: Increased need for better methods. Emerging Infectious Diseases 1(4): 115-123.
52. Van Rie A. (2013) Xpert MTB/RIF: A game changer for the diagnosis of pulmonary tuberculosis in children? Lancet Global Health 1(2): e60-e61.
53. World Health Organization. (2013) Automated real-time nucleic acid amplification technology for rapid and simultan eous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children. Policy update. Geneva, Switzerland: World Health Organization.
54. Walls T. and Shingadia D. (2004) Global epidemiology of paediatric tuberculosis. Journal of Infection 48(1): 13-22.
55. Brent A.J. (2012) Childhood TB surveillance: Bridging the knowledge gap to inform policy. Journal of Tropical Medicine. Article ID 865436.
56. World Health Organization. (2011) Tuberculosis Prevalence Surveys: A Handbook. Geneva, Switzerland: World Health Organization.
57. Graham S.M., Sismanidis C., Menzies H.J., Marais B.J., Detjen A.K. and Black R.E. (2014) Importance of tuberculosis control to address child survival. The Lancet 383(9928): 1605-1607.
58. Centers for Disease Control and Prevention. (2005) Guidelines for the Investigation of Contacts of Persons With Infections Tuberculosis. Recommendations from the National Tuberculosis Controllers Association and the CDC. Morbidity and Mortality Weekly Report 54 (No. RR-15).
59. Hsu K.H. (1984) Thirty years after isoniazid. Its impact on tuberculosis in children and adolescents. Journal of the American Medical Association 251(10): 1283-1285.
60. Centers for Disease Control and Prevention. (1990) The Use of Preventive Therapy for Tuberculous Infection in the United States. Recommendations of the Advisory Committee for Elimination of Tuberculosis. Morbi dity and MortalityWeekly Report 39 (No. RR-8), pp. 9-12.
61. Centers for Disease Control and Prevention. (1995) Essential Components of a Tuberculosis Prevention and Control Program. Recommendations of the Advisory C ouncil for the Elimination of Tuberculosis. Morbidity and Mortality Weekly Report 44 (No. RR-11).
62. Morrison J., Pai,M. and Hopewell P.C. (2008) Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: A systematic review and meta-analysis. The Lancet Infectious Diseases 8(6): 359-368.
63. Fox G.J., Barry S.E., Britton W.J. and Marks G.B. (2013) Contact investigation for tuberculosis: A systematic review and meta-analysis. European Respiratory Journal 41(1): 140-156.
64. Shah N.S., Yuen C.M., Heo M., Tolman A.W. and Becerra M.C. (2014) Yield of contact investigations in households of patients with drug-resistant tuberculosis: Systematic review and meta-analysis. Clinical Infectious Diseases 58(3): 381-391.
65. World Health Organization. (2013) Systematic Screening for Active Tuberculosis: Principles and Recommendations. Geneva, Switzerland: World Health Organization.
66. World Health Organization. (2012 ) Recommendations for Investigating Contacts of Person with Infectious Tuberculosis in Low-and Middle-Income Countries. Geneva, Switzerland: World Health Organization.
67. van der Werf M.J. Langendam M.W. Sandgren A. Manissero D. 2012 Lack of evidence to support policy development for management of contacts of multidrug-resistant tuberculosis patients: Two systematic reviews International Journal of Tuberculosis and Lung Disease 16 3 288-296.
68. Schaaf H.S., Gie R.P., Kennedy M., Beyers N., Hesseling P.B. and Donald P.R. (2002) Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis : A 30-month follow-up. Pediatrics 109(5): 765-771.
69. Seddon J.A., Godfrey-Faussett P., Hesseling A.C., Gie R.P., Beyers N. and Schaaf H.S. (2012) Management of children exposed to multidrug-resistant Mycobacterium tuberculosis. The Lancet Infectious Diseases 12(6): 469-479.
70. European Center for Disease Prevention and Control. (2012) Management of contacts of MDR TB and XDR TB patients. Stockholm, Sweden: European Center for Disease Prevention and Control, http://www.ecdc.europa.eu/en/publications/publications/201203-guidance-mdrtb-contacts.pdf, accessed 15 April 2013.
71. Seddon J.A. et al (2013 ) Preventive therapy for child contacts of multidrug-resistant tuberculosis: A prospective cohort study. Clinical Infectious Diseases 57(12): 1676-1684.
72. Feja K., McNelley E., Tran C.S., Burzynski J. and Saiman L. (2008) Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003. The Pediatric Infectious Disease Journal 27(10): 907-912.
73. Bamrah S. et al (2014) Treatment for LTBI in contacts to MDR-TB-Federated States of Micronesia, 2009-2012. International Journal of Tuberculosis and Lung Disease 18(8): 912-918.
74. Hsu K.H. (1963) Contact investigation: A practical approach to tuberculosis eradication. American Journal of Public Health and the Nation's Health 53(11): 1761-1769.
75. Nolan R.J. Jr (1986) Childhood tuberculosis in North Carolina: A study of the opportunities for intervention in the transmission of tuberculosis to children. American Journal of Public Health 76(1): 26-30.
76. Mehta J.B . and Bentley S. (1992) Prevention of tuberculosis in children: Missed opportunities. American Journal of Preventive Medicine 8(5): 283-286.
77. Starke J.R. (1996) Tuberculosis skin testing: New schools of thought. Pediatrics 98(1): 123-125.
78. Starke J.R. (2003) Pediatric tuberculosis: Time for a new approach. Tuberculosis (Edinb) 83(1-3): 208-212.
79. Mandalakas A.M., Hesseling A.C., Gie R.P., Schaaf H.S., Marais B.J. and Sinanovic E. (2013) Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting . Thorax 68(3): 247-255.
80. Hill P.C., Rutherford M.E., Audas R., van Crevel R. and Graham S.M. (2011) Closing the policy-practice gap in the management of child contacts of tuberculosis cases in developing countries. PLOS Medicine 8(10): e1001105.
81. Rutherford,M.E., Hill P.C., Triasih R., Sinfield R., van Crevel R. and Graham S.M. (2012) Preventive therapy in children exposed to Mycobacterium tuberculosis: Problems and solutions. Tropical Medicine & International Health 17(10): 1264-1273.
82. Beyers N. et al (1997) A prospective evaluation of children under the age of 5 years living in the same household as adults with recently diagnosed pulmonary tuberculosis. International Journal of Tube rculosis and Lung Disease 1(1): 38-43.
83. Grzybowski S., Barnett G.D. and Styblo K. (1975) Contacts of cases of active pulmonary tuberculosis. Bulletin of the International Union Against Tuberculosis and Lung Disease 50(1): 90-106.
84. Jaganath D. et al (2013) Contact investigation for active tuberculosis among child contacts in Uganda. Clinical Infectious Diseases 57(12): 1685-1692.
85. Enarson D.A. (2004) Children and the global tuberculosis situation. Paediatric Respiratory Reviews 5(Suppl. A): S143-145.
86. Starke J.R., Jacobs R.F. and Jereb, J . (1992) Resurgence of tuberculosis in children. Journal of Pediatrics 120(6): 839-855.
87. Ussery X.T., Valway S.E., McKenna M., Cauthen G.M., McCray E. and Onorato I.M. ( 1996) Epidemiology of tuberculosis among children in the United States: 1985 to 1994. The Pediatric Infectious Disease Journal 15(8): 697-704.
88. Jereb J.A., Kelly G.D., Dooley S.W., Cauthen G.M. Jr. and Snider D.E. Jr. (1991) Tuberculosis morbidity in the United States: Final data, 1990. Morbidity and Mortality Weekly Report Surveillance Summaries 40(3): 23-27.
89. Kimerling M.E., Barker J.T., Bruce, F., Brook N.L. and Dunlap N.E. (2000) Preventable childhood tuberculosis in Alabama: Implications and opportunity. Pediatrics 105(4): E53.
90. Marquez L., Feske M.L., Teeter L.D., Musser J.M. and Graviss E.A. (2012) Pediatric tuberculosis: The litmus test for tuberculosis control. The Pediatric Infectious Disease Journal 31(11): 1144-1147.
91. Steiner P., Rao M., Mitchell M. and Steiner M. (1985) Primary drug-resistant tuberculosis in children. Correlation of drug-susceptibility patterns of matched patient and source case strains of Mycobacterium tuberculosis. American Journal of Diseases of Children 139(8): 780-782.
92. Rieder H.L. (1993) Drug-resistant tuberculosis: Issues in epidemiology and challenges for public health. Tubercle and Lung Disease 75(5): 321-323.
93. Donald P.R., Maher D. and Qazi S. (2007) A research agenda to promote the management of childhood tuberculosis within national tu berculosis programmes. International Journal of Tuberculosis and Lung Disease 11(4): 370-380.
94. Schaaf H.S., Gie R.P., Beyers N., Sirgel, F.A., de Klerk P.J. and Donald P.R. (2000) Primary drug-resistant tuberculosis in children. International Journal of Tuberculosis and Lung Disease 4(12): 1149-1155.
95. Swaminathan S. et al (2008) A profile of bacteriologically confirmed pulmonary tuberculosis in children. Indian Pediatrics 45(9): 743-747.
96. Fairlie L., Beylis N.C., Reubenson G., Moore D.P. and Madhi S.A. (2011) High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: A cross sectional study. BMC Infectious Diseases 11: article 28.
97. Schaaf H.S. et al (2000) Transmission of multidrug-resistant tuberculosis. The Pediatric Infectious Disease Journal 19(8): 695-699.
98. Becerra M.C. et al (2013) Tuberculosis in children exposed at home to multidrug-resistant tuberculosis. The Pediatric Infectious Disease Journal 32(2): 115-119.
99. Amanullah, F. et al (2014) High tuberculosis prevalence in children exposed at home to drug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease 18(5): 520-527.
100. Heymann S.J., Brewer T.F., Wilson M.E., Colditz G.A. and Fineberg H.V. (2000) Pediatric tuberculosis: What needs to be done to decrease morbidity and mortality. Pediatrics 106(1): E1.
101. Becerra M.C. and Swaminathan S. (2011) The way forward: Partnerships for scaling up paediatric DR-TB care. Paper presented at the 42nd UnionWorld Conference on Lung Health; 28 October, Lille, France.
102. The Sentinel Project on Pediatric Drug-Resistant Tuberculosis. (2012) Being Brave: Stories of Children with Drug-Resistant Tuberculosis. Boston, MA: The Sentinel Project on Pediatric Drug-Resistant Tuberculosis , http://sentinelproject.files.wordpress.com/2012/03/stories-of-children-with-dr-tb2.pdf, accessed 15 April 2013.
103. The Sentinel Project on Pediatric Drug-Resistant Tuberculosis, and Treatment Action Group. (2013) 'We C an Heal': Prevention, diagnosis, treatment, care, and support: Addressing drugresistant tuberculosis in children. New York: The Sentinel Project on Pediatric Drug-Resistant Tuberculosis and Treatment Action Group, http://sentinelproject.files.wordpre ss.com/2013/03/sentinel-project-we-can-heal-20131.pdf, accessed 15 April 2013.
104. The Sentinel Project on Pediatric Drug-Resistant Tuberculosis. (2012) Management of Multidrug-Resistant Tuberculosis in Children: A Field Guide. Boston, MA: The Sentinel Project on Pediatric Drug-Resistant Tuberculosis, http://www.sentinel-project.org/treatment-guidance/, accessed 15 April 2013.
105. Seddon J.A. et al (2013) Consensus statement on research def initions for drug-resistant tuberculosis in children. Journal of the Pediatric Infectious Diseases Society 2(2): 100-109.
106. Cohen T., Colijn C., Wright A., Zignol M., Pym A. and Murra y M. (2008) Challenges in estimating the total burden of drug-resistant tuberculosis. American Journal of Respiratory and Critical Care Medicine 177(12): 1302-1306.
107. Chin J., Sato P.A. and Mann J.M. (1990) Projections of HIV infections and AIDS cases to the year 2000. Bulletin of the World Health Organization 68(1): 1-11.
108. Schwartlander B. et al (2001) Resource needs for HIV/AIDS. Science 292(5526): 2434-2436.
109. Williams B. et al (2013) Management of pediatric contacts of multidrug resistant tuberculosis in the United Kingdom. The Pediatric Infectious Disease Journal 32(8): 926-927.
110. SF1.1: Family size and household composition From: OECD. 2012) OECD Family Database. Paris, France: OECD. http://www.oecd.org/social/family/database, accessed 15 April 2013.
111. Graham S.M. et al (2012) Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. The Journal of Infectious Diseases 205(Suppl. 2): S199-208.
112. Schaaf H.S. and Marais B.J. (2011) Management of multidrug-resistant tuberculosis in children: A survival guide for paediatricians. Paediatric Respiratory Reviews 12(1): 31-38.
113. Comstock G.W., Baum C. and Snider D.E. Jr. (1979) Isoniazid prophylaxis among Alaskan Eskimos: A final report of the Bethel isoniazid studies. American Review of Respiratory Disease 119(5): 827-830.
114. Marais B.J. et al (2004) The natural history of childhood intra-thoracic tuberculosis: A critical review of literature from the pre-chemotherapy era. International Journal of Tuberculosis and Lung Disease 8(4): 392-402.
115. Nachega J. et al (2003) Tuberculosis active case-finding in a mother-to-child HIV transmission prevention programme in Soweto, South Africa. AIDS 17(9): 1398-1400.
116. Kali P.B., Gray G.E., Violari A., Chaisson R.E., McIntyre J.A. and Martinson N.A. (2006) Combining PMTCT with active case finding for tuberculosis. Journal of Acquired Immune Deficiency Syndromes 42(3): 379-381.
117. Gupta A. et al (2007) Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005. Clinical Infectious Diseases 45(2): 241-249.
118. Talukder K. et al (2012) Intervention to increase detection of childhood tuberculosis in Bangladesh. International Journal of Tuberculosis and Lung Disease 16(1): 70-75.
119. Lobato M.N. et al (2008) Underuse of effective measures to prevent and manage pediatric tuberculosis in the United States. Archives of Pediatrics an d Adolescent Medicine 162(5): 426-431.
120. Seddon J.A. et al (2012) Paediatric use of second-line anti-tuberculosis agents: A review. Tuberculosis (Edinb) 92(1): 9-17.